Epidemiology of diabetic retinopathy and macular oedema: a systematic review

R Williams, M Airey, H Baxter, J Forrester, T Kennedy-Martin, A Girach

Research output: Contribution to journalLiterature review

250 Citations (Scopus)

Abstract

Aims To systematically review the literature on the prevalence and incidence of diabetic retinopathy (DR) and macular oedema ( MO).

Methods A search of the bibliographic databases (Medline, Embase, CINAHL) was conducted up to October 2001. Selected relevant studies were scrutinized and included in the review.

Results A total of 359 studies were included. The studies were reported in nearly 100 different journals and in over 50 countries. The majority of the studies were US-based, with large studies such as the Wisconsin Epidemiologic Study of Diabetic Retinopathy dominating the literature. The studies were quite dated and highly heterogeneous in nature in terms of patient selection with variable inclusion criteria ( age range, gender, diabetes duration and type, ethnicity, comorbidity, and DR status, assessment, and classification).

Conclusions There are inconsistencies between epidemiological studies, and differences in study methods may contribute to conflicting reports of prevalence and incidence of DR and MO in diabetic populations. As new therapies for DR and its associated complications emerge, the need to capture and monitor new epidemiological data becomes increasingly important to be able to assess the impact and effectiveness of these therapies. Robust, longitudinal capture of patient data is, therefore, essential to evaluate the impact of current practice on the epidemiology of diabetic eye complications.

Original languageEnglish
Pages (from-to)963-983
Number of pages21
JournalExperimental Eye Research
Volume18
DOIs
Publication statusPublished - 2004

Keywords

  • diabetic retinopathy
  • macular oedema
  • epidemiology
  • diabetes complications
  • incidence
  • prevalence
  • LONG-TERM COMPLICATIONS
  • NON-HISPANIC WHITES
  • IMPAIRED GLUCOSE-TOLERANCE
  • 4-YEAR FOLLOW-UP
  • INSULIN-DEPENDENT DIABETICS
  • ELEVATED BLOOD-PRESSURE
  • RISK-FACTORS
  • EYE DISEASE
  • METABOLIC-CONTROL
  • GLYCEMIC CONTROL

Cite this

Williams, R., Airey, M., Baxter, H., Forrester, J., Kennedy-Martin, T., & Girach, A. (2004). Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Experimental Eye Research, 18, 963-983. https://doi.org/10.1038/sj.eye.6701476

Epidemiology of diabetic retinopathy and macular oedema: a systematic review. / Williams, R ; Airey, M ; Baxter, H ; Forrester, J ; Kennedy-Martin, T ; Girach, A .

In: Experimental Eye Research, Vol. 18, 2004, p. 963-983.

Research output: Contribution to journalLiterature review

Williams, R, Airey, M, Baxter, H, Forrester, J, Kennedy-Martin, T & Girach, A 2004, 'Epidemiology of diabetic retinopathy and macular oedema: a systematic review', Experimental Eye Research, vol. 18, pp. 963-983. https://doi.org/10.1038/sj.eye.6701476
Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Experimental Eye Research. 2004;18:963-983. https://doi.org/10.1038/sj.eye.6701476
Williams, R ; Airey, M ; Baxter, H ; Forrester, J ; Kennedy-Martin, T ; Girach, A . / Epidemiology of diabetic retinopathy and macular oedema: a systematic review. In: Experimental Eye Research. 2004 ; Vol. 18. pp. 963-983.
@article{b702643f35664d0993464ad0f259e770,
title = "Epidemiology of diabetic retinopathy and macular oedema: a systematic review",
abstract = "Aims To systematically review the literature on the prevalence and incidence of diabetic retinopathy (DR) and macular oedema ( MO).Methods A search of the bibliographic databases (Medline, Embase, CINAHL) was conducted up to October 2001. Selected relevant studies were scrutinized and included in the review.Results A total of 359 studies were included. The studies were reported in nearly 100 different journals and in over 50 countries. The majority of the studies were US-based, with large studies such as the Wisconsin Epidemiologic Study of Diabetic Retinopathy dominating the literature. The studies were quite dated and highly heterogeneous in nature in terms of patient selection with variable inclusion criteria ( age range, gender, diabetes duration and type, ethnicity, comorbidity, and DR status, assessment, and classification).Conclusions There are inconsistencies between epidemiological studies, and differences in study methods may contribute to conflicting reports of prevalence and incidence of DR and MO in diabetic populations. As new therapies for DR and its associated complications emerge, the need to capture and monitor new epidemiological data becomes increasingly important to be able to assess the impact and effectiveness of these therapies. Robust, longitudinal capture of patient data is, therefore, essential to evaluate the impact of current practice on the epidemiology of diabetic eye complications.",
keywords = "diabetic retinopathy, macular oedema, epidemiology, diabetes complications, incidence, prevalence, LONG-TERM COMPLICATIONS, NON-HISPANIC WHITES, IMPAIRED GLUCOSE-TOLERANCE, 4-YEAR FOLLOW-UP, INSULIN-DEPENDENT DIABETICS, ELEVATED BLOOD-PRESSURE, RISK-FACTORS, EYE DISEASE, METABOLIC-CONTROL, GLYCEMIC CONTROL",
author = "R Williams and M Airey and H Baxter and J Forrester and T Kennedy-Martin and A Girach",
year = "2004",
doi = "10.1038/sj.eye.6701476",
language = "English",
volume = "18",
pages = "963--983",
journal = "Experimental Eye Research",
issn = "0014-4835",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Epidemiology of diabetic retinopathy and macular oedema: a systematic review

AU - Williams, R

AU - Airey, M

AU - Baxter, H

AU - Forrester, J

AU - Kennedy-Martin, T

AU - Girach, A

PY - 2004

Y1 - 2004

N2 - Aims To systematically review the literature on the prevalence and incidence of diabetic retinopathy (DR) and macular oedema ( MO).Methods A search of the bibliographic databases (Medline, Embase, CINAHL) was conducted up to October 2001. Selected relevant studies were scrutinized and included in the review.Results A total of 359 studies were included. The studies were reported in nearly 100 different journals and in over 50 countries. The majority of the studies were US-based, with large studies such as the Wisconsin Epidemiologic Study of Diabetic Retinopathy dominating the literature. The studies were quite dated and highly heterogeneous in nature in terms of patient selection with variable inclusion criteria ( age range, gender, diabetes duration and type, ethnicity, comorbidity, and DR status, assessment, and classification).Conclusions There are inconsistencies between epidemiological studies, and differences in study methods may contribute to conflicting reports of prevalence and incidence of DR and MO in diabetic populations. As new therapies for DR and its associated complications emerge, the need to capture and monitor new epidemiological data becomes increasingly important to be able to assess the impact and effectiveness of these therapies. Robust, longitudinal capture of patient data is, therefore, essential to evaluate the impact of current practice on the epidemiology of diabetic eye complications.

AB - Aims To systematically review the literature on the prevalence and incidence of diabetic retinopathy (DR) and macular oedema ( MO).Methods A search of the bibliographic databases (Medline, Embase, CINAHL) was conducted up to October 2001. Selected relevant studies were scrutinized and included in the review.Results A total of 359 studies were included. The studies were reported in nearly 100 different journals and in over 50 countries. The majority of the studies were US-based, with large studies such as the Wisconsin Epidemiologic Study of Diabetic Retinopathy dominating the literature. The studies were quite dated and highly heterogeneous in nature in terms of patient selection with variable inclusion criteria ( age range, gender, diabetes duration and type, ethnicity, comorbidity, and DR status, assessment, and classification).Conclusions There are inconsistencies between epidemiological studies, and differences in study methods may contribute to conflicting reports of prevalence and incidence of DR and MO in diabetic populations. As new therapies for DR and its associated complications emerge, the need to capture and monitor new epidemiological data becomes increasingly important to be able to assess the impact and effectiveness of these therapies. Robust, longitudinal capture of patient data is, therefore, essential to evaluate the impact of current practice on the epidemiology of diabetic eye complications.

KW - diabetic retinopathy

KW - macular oedema

KW - epidemiology

KW - diabetes complications

KW - incidence

KW - prevalence

KW - LONG-TERM COMPLICATIONS

KW - NON-HISPANIC WHITES

KW - IMPAIRED GLUCOSE-TOLERANCE

KW - 4-YEAR FOLLOW-UP

KW - INSULIN-DEPENDENT DIABETICS

KW - ELEVATED BLOOD-PRESSURE

KW - RISK-FACTORS

KW - EYE DISEASE

KW - METABOLIC-CONTROL

KW - GLYCEMIC CONTROL

U2 - 10.1038/sj.eye.6701476

DO - 10.1038/sj.eye.6701476

M3 - Literature review

VL - 18

SP - 963

EP - 983

JO - Experimental Eye Research

JF - Experimental Eye Research

SN - 0014-4835

ER -